![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Mekota, Anna -Maria; Gillespie, Stephen H.; Hoelscher, Michael; Diacon, Andreas H.; Dawson, Rodney; Churchyard, Gavin; Sanne, Ian; Minja, Lilian; Kibiki, Gibson; Maboko, Leonard; Lakhi, Shabir; Joloba, Moses; Alabi, Abraham; Kirenga, Bruce; McHugh, Timothy D.; Grobusch, Martin P. und Boeree, Martin J.
(2022):
Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach.
In: Acta Tropica, Bd. 238, 106776
Rachow, Andrea; Ivanova, Olena; Wallis, Robert; Charalambous, Salome; Jani, Ilesh; Bhatt, Nilesh; Kampmann, Beate; Sutherland, Jayne; Ntinginya, Nyanda E.; Evans, Denise; Lönnroth, Knut; Niemann, Stefan; Schaible, Ulrich E.; Geldmacher, Christof; Sanne, Ian; Hölscher, Michael und Churchyard, Gavin
(2019):
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB – a study protocol.
In: BMC Pulmonary Medicine
19:4
[PDF, 755kB]
Di Tanna, Gian Luca; Khaki, Ali Raza; Theron, Grant; McCarthy, Kerrigan; Cox, Helen; Mupfumi, Lucy; Trajman, Anete; Zijenah, Lynn Sodai; Mason, Peter; Durovni, Retina; Bara, Wilbert; Hoelscher, Michael; Clowes, Petra; Mangu, Chacha; Chanda, Duncan; Pym, Alexander; Mwaba, Peter; Cobelens, Frank; Nicol, Mark P.; Dheda, Keertan; Churchyard, Gavin; Fielding, Katherine; Metcalfe, John Z. und Bandason, Tsitsi
(2019):
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis.
In: Lancet Global Health, Bd. 7, Nr. 2, E191-E199
Svensson, Elin M.; Svensson, Robin J.; te Brake, Lindsey H. M.; Böree, Martin J.; Heinrich, Norbert; Konsten, Sarah; Churchyard, Gavin; Dawson, Rodney; Diacon, Andreas H.; Kibiki, Gibson S.; Minja, Lilian T.; Ntingiya, Nyanda E.; Saone, Ian; Gillespie, Stephen H.; Hölscher, Michael; Phillips, Patrick P. J.; Simonsson, Ulrika S. H. und Aarnoutse, Rob
(2018):
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
In: Clinical Infectious Diseases, Bd. 67, Nr. 1: S. 34-41
Boeree, Martin J.; Heinrich, Norbert; Aarnoutse, Rob; Diacon, Andreas H.; Dawson, Rodney; Rehal, Sunita; Kibiki, Gibson S.; Churchyard, Gavin; Sanne, Ian; Ntinginya, Nyanda E.; Minja, Lilian T.; Hunt, Robert D.; Charalambous, Salome; Hanekom, Madeleine; Semvua, Hadija H.; Mpagama, Stellah G.; Manyama, Christina; Mtafya, Bariki; Reither, Klaus; Wallis, Robert S.; Venter, Amour; Narunsky, Kim; Mekota, Anka; Henne, Sonja; Colbers, Angela; Plemper van Balen, Georgette; Gillespie, Stephen H.; Phillips, Patrick P. J. und Hölscher, Michael
(2017):
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
In: Lancet infectious Diseases, Bd. 17, Nr. 1: S. 39-49
Wallis, Robert S.; Maeurer, Markus; Mwaba, Peter; Chakaya, Jeremiah; Rustomjee, Roxana; Migliori, Giovanni Battista; Marais, Ben; Schito, Marco; Churchyard, Gavin; Swaminathan, Soumya; Hölscher, Michael und Zumla, Alimuddin
(2016):
Tuberculosis - advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers.
In: Lancet infectious Diseases, Bd. 16, Nr. 4, E34-E46